Lv1
20 积分 2023-11-07 加入
A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed/refractory acute myeloid leukemia
2个月前
已完结
A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed/refractory acute myeloid leukemia
2个月前
已关闭
Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction: a single-centre, single-arm, phase 2 trial
2个月前
已完结
Treatment for relapsed acute promyelocytic leukemia
3个月前
已完结
Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet
3个月前
已完结
Biomarkers to Differentiate Acute Chest Syndrome From Vaso‐Occlusive Crisis in Children With Sickle Cell Disease
5个月前
已完结
Targeting DDX11 promotes PARP inhibitor sensitivity in hepatocellular carcinoma by attenuating BRCA2-RAD51 mediated homologous recombination
5个月前
已完结
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias
8个月前
已完结
CRISPR-based rapid molecular diagnostic tests for fusion-driven leukemias
8个月前
已关闭
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML
9个月前
已完结
皖公网安备34019202002308
